Capital Development Associate

About the Company

Redesign Health is a global venture builder that empowers founders to launch and scale transformative healthcare companies. We help founders overcome the unique challenges of healthcare innovation with a suite of capabilities supporting ideation, commercial traction, and execution. Since 2018, we have backed founders to launch more than 65 companies that have touched the lives of over 15 million patients and generated more than $1 billion in revenue.

We believe we can create breakthrough innovations in global health technology through grit, technical excellence, and teamwork. We seek out builders who share our ambitious vision.

Redesign Health is dedicated to launching AI‑native healthcare ventures that transform how care is delivered and experienced. Like the startups we build, we embed AI deeply into all our operations, empowering our team to focus their creativity and expertise on the most complex challenges and high‑impact opportunities. We’re seeking curious, adaptable individuals who are excited to explore new ways of working, eager to constantly experiment, and committed to pushing the boundaries of what’s possible at the intersection of human ingenuity and artificial intelligence.

The Capital Development Associate will play a pivotal role in supporting our team and senior leadership on business development and fundraising initiatives, enabling a robust sales intelligence and research process for expansion strategies, manage relationships with current and prospective investors, and serve as an analytical partner across the organization.

This role involves preparing reports, analyzing data, coordinating investor communications, and supporting fundraising and investor engagement activities. You will also help drive analytical rigor for managing and monitoring our portfolio of 60+ healthcare businesses and will support Redesign and operating company CEOs in structuring investments and commercial partnerships.

In this role, you will report to Redesign’s Head of Capital Development. This is a highly visible and cross‑functional role, in which you will interact closely with the entire Strategy & Finance and portfolio management organizations, as well as operating company CEOs and Redesign investors.

• Assist in the development and execution of the firm’s investor relations strategy.
• Own the preparation of quarterly and annual reports, investor presentations, and newsletters.
• Manage and maintain investor relations databases (Allvue, Affinity, Canva) and ensure accuracy and completeness of all information.
• Make recommendations on changes to existing Investor Relations processes and systems to improve team efficiency and quality of information shared with LPs.
• Coordinate and attend investor meetings, calls, and events.
• Respond to IR inbox requests in a timely and professional manner, looping in the appropriate internal team members as needed and taking accountability for quality responses.

• Prepare reports on company and fund performance, financial and valuation models, and benchmarking analyses for investors.
• Provide analytical support on company cap tables, including waterfall analysis, understanding of preferred vs. common equity and related terms, and performance metrics (MOIC, DPI, IRR).
• Lead valuation process with leadership committee, following valuation policies and procedures to calibrate fair market values reported to investors on a quarterly and ad hoc basis.
• Assume ownership of key finance/fundraising work streams, including portfolio reporting and the production of compelling investor materials.

• Drive the preparation of marketing materials for prospective investors.
• Support the execution of fundraising campaigns and capital‑raising initiatives, including market mapping, prospecting lists, and standard DDQ items.
• Track investor pipeline activity in Redesign’s CRM and provide regular updates and insights to senior management.

• 2‑3 years of experience in banking, consulting, or at a high‑growth startup. Experience in investor relations and/or company…